食管胃底静脉曲张破裂出血预防和治疗进展*

doi:10.3969/j.issn.1672-5069.2021.04.039

摘要/Abstract

摘要： 目的食管胃底静脉曲张破裂出血是肝硬化常见的并发症, 病死率高。因此,预防和治疗食管胃底静脉曲张破裂出血对于肝硬化患者非常重要。药物治疗、内镜治疗、介入治疗和外科手术治疗等都是预防和治疗该病的重要手段,各有疗效,极大地提高了患者生存率。本文针对不同食管胃底静脉曲张类型的一级预防、急症止血和二级预防治疗现状及研究进展作一综述。

关键词: 肝硬化, 食管胃底静脉曲张, 一级预防, 急症止血, 二级预防

Abstract: Objective Esophageal and gastric varices bleeding (EGVB) is a common complications of liver cirrhosis, with a high mortality rate. Therefore, the prevention and treatment of EGVB is very important for patients with liver cirrhosis. Internal medicine, endoscopic management, interventional and surgical operation are all important approaches for the prevention and treatment of EGVB, which greatly improves the survival rate of cirrhotic patients. In this paper, we reviewed the current progress of primary prevention, emergent hemostasis and secondary prevention of patients with different types of esophageal and gastric varices.

Key words: Liver cirrhosis, Esophagogastric varices, Primary prevention, Emergent hemostasis, Secondary prevention

孙若楠, 张春清. 食管胃底静脉曲张破裂出血预防和治疗进展^*[J]. 实用肝脏病杂志, 2021, 24(4): 607-610.

Sun Ruonan, Zhang Chunqing. Prevention and treatment of cirrhotics with esophagus and gastric varices bleeding[J]. Journal of Practical Hepatology, 2021, 24(4): 607-610.

参考文献

[1] Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology, 2008,134(6):1715-1728.
[2] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guid- ance by the American Association for the study of liver diseases. Hepatology,2017,65(1):310-335.
[3] Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology,1992,16(6):1343-1349.
[4] Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Epatol,1991,13(3):274-278.
[5] Sharma BC, Varakanahalli S, Singh JP, et al. Gastric varices in cirrhosis vs. extrahepatic portal venous obstruction and response to endoscopic N-butyl-2-cyanoacrylate injection. J Clin Exp Hepatol,2017,7(2):97-101.
[6] Karadsheh Z, Allison H. Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci,2013,5(10):573-579.
[7] Bañares R, Moitinho E, Matilla A, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology,2002,36(6):1367-1373.
[8] Shah HA, Azam Z, Rauf J, et al. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J Hepatol,2014,60(4):757-764.
[9] Bai M,Qi X,Yang M,et al. Combined therapies versus monotherapies for the first variceal bleeding in patients with high- risk varices:a meta- analysis of randomized controlled trials. J Gastroenterol Hepatol,2014,29(3):442- 452.
[10] Santos MM, Tolentino LH, Rodrigues RA, et al. Endoscopic treatment of esopha- geal varices in advanced liver disease patients: band ligation versus cyanoacry- late injection. Eur J Gastroenterol Hepatol,2011,23(1):60-65.
[11] de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63(3):743-752.
[12] Mishra SR, Sharma BC, Kumar A, et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol,2011,54(6):1161-1167.
[13] European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol,2018,69(2): 406-460.
[14] Dai C, Liu WX, Jiang M, et al. Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage:a meta-analysis. World J Gastroenterol,2015,21(8):2534-2541.
[15] 庄辛福,张宝东,程文芳.套扎与硬化对肝硬化食管静脉曲张疗效的Meta分析.胃肠病学和肝病学杂志,2013,22( 4) :375-379.
[16] Rios Castellanos E, Seron P, Gisbert JP, et al. Endoscopic injection of cyanoac- rylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev,2015,(5):CD010180.
[17] Binmoeller KF, Weilert F, Shah JN, Kim J. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos). Gastrointest Endosc,2011,74(5):1019-1025.
[18] Robles-Medranda C, Oleas R, Valero M, et al. Endoscopic ultrasonography-guided deployment of embolization coils and cyanoacrylate injection in gastric varices versus coiling alone: a randomized trial. Endoscopy,2020,52(4):268-275.
[19] 冯凯祥,于剑波,杨培,等.聚桂醇纤维蛋白原凝血酶序贯法治疗胃底静脉曲张出血.西南国防医药,2017,27(01):8-11.
[20] Kapoor A, Dharel N, Sanyal AJ. Endoscopic diagnosis and therapy in gastroesophageal variceal bleeding. Gastrointest Endosc Clin N Am,2015,25(3):491-507.
[21] Garcia-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol,2013,58(1):45-50.
[22] Lyu Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol,2019,4(8):587-598.
[23] Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol,2002,37(5):703-704.
[24] 石青,郭武华.介入治疗肝硬化门脉高压症并发食管胃底静脉曲张破裂出血研究进展.实用肝脏病杂志,2016,19( 5) : 519-523.
[25] Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet,2003,361(9361):952-954.
[26] Bernard B, Lebrec D, Mathurin P, et al. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology,1997,25(1):63-70.
[27] Thiele M, Krag A, Rohde U, et al. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther,2012,35(10):1155-1165.
[28] Gonzalez R, Zamora J, Gomez-Camarero J, et al. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med,2008,149(2):109-122.
[29] Lin LL, Du SM, Fu Y, et al. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget,2017,8(34):57399-57408.
[30] Michael PG, Antoniades G, Staicu A, et al. Pulmonary glue embolism: An unusual complication following endoscopic sclerotherapy for gastric varices. Sultan Qaboos Univ Med J,2018,18(2):e231-e235.
[31] 章復龙,朱元东,徐晶,等.组织胶联合金属夹治疗孤立性胃底静脉曲张(IGV1型)21例疗效分析.中国内镜杂志,2017,23(7):100-103.
[32] 施言,吴乾能,谢欣城,等.内镜下钛夹联合组织胶治疗GOV2型胃底静脉曲张30例.中国内镜杂志,2017,23(12):88-92.
[33] McCarty TR, Bazarbashi AN, Hathorn KE, et al. Combination therapy versus monotherapy for EUS-guided management of gastric varices: A systematic review and meta-analysis. Endosc Ultrasound,2020,9(1):6-15.
[34] Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy,2007,39(8):679-685.
[35] Sabri SS, Abi-Jaoudeh N, Swee W, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol,2014,25(3):355-361.

食管胃底静脉曲张破裂出血预防和治疗进展^*

Prevention and treatment of cirrhotics with esophagus and gastric varices bleeding

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘颖, 何显, 田志颖, 赵晓彦. 乙型肝炎肝硬化并发急性肾损伤患者临床特点及其危险因素分析^*[J]. 实用肝脏病杂志, 2021, 24(4): 524-527.
[2]	金苏素, 颜华东. 血清肾上腺髓质素前体诊断失代偿期肝硬化并发细菌感染及其预测短期预后的价值^*[J]. 实用肝脏病杂志, 2021, 24(4): 528-531.
[3]	江秋维, 黄理, 姚朝光. 乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者临床特征及其危险因素分析^*[J]. 实用肝脏病杂志, 2021, 24(4): 532-535.
[4]	冯娟, 哈丽达·夏尔甫哈孜, 范晓棠, 任智慧, 才仁, 李亮, 何方平. 合并MAFLD的乙型肝炎肝硬化患者血清瘦素水平变化特点分析^*[J]. 实用肝脏病杂志, 2021, 24(4): 536-539.
[5]	高慧茹, 高会斌, 彭昭, 王璐, 霍小辉. 乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者临床特征及影响因素分析[J]. 实用肝脏病杂志, 2021, 24(3): 395-398.
[6]	王云强, 王丽萍, 黄冬梅, 王艳彬, 刘晓杰, 李明宇, 赵欣宇. 经颈静脉肝内门体静脉分流术治疗乙型肝炎肝硬化门脉高压症患者疗效和血流动力学变化分析[J]. 实用肝脏病杂志, 2021, 24(3): 399-402.
[7]	伍畅, 张远安, 彭春芬. 内镜下套扎术后应用卡维地洛治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(3): 403-406.
[8]	南东, 洪金玲, 姜海宇. 应用DCE-MRI技术评估乙型肝炎肝硬化患者食管胃底静脉曲张严重程度的效能分析[J]. 实用肝脏病杂志, 2021, 24(3): 407-410.
[9]	李华, 温江华, 吴英春, 潘宇翔. 酒精性肝硬化患者临床特征分析[J]. 实用肝脏病杂志, 2021, 24(3): 411-414.
[10]	周慧, 冯晓宁, 任浩, 刘杜先, 杨永峰, 熊清芳. 非肝硬化门脉高压患者临床特点分析[J]. 实用肝脏病杂志, 2021, 24(3): 415-418.
[11]	赵凯, 薛晋峰, 薛鹏飞, 常鹏. Viatorr覆膜支架用于TIPS术治疗肝硬化门静脉高压症患者预后研究[J]. 实用肝脏病杂志, 2021, 24(3): 419-422.
[12]	谢宁, 黄娟秀, 严柳媚, 廖小莉. 长期核苷(酸)类抗病毒治疗的乙型肝炎肝硬化患者肝癌发生相关因素研究[J]. 实用肝脏病杂志, 2021, 24(3): 423-426.
[13]	王江丽, 裴凌燕, 贺晶晶, 李岚, 袁佳健, 夏莉婷, 崔雯. 血清PTX3和sTWEAK预测失代偿期乙型肝炎肝硬化患者死亡临床价值分析[J]. 实用肝脏病杂志, 2021, 24(2): 236-239.
[14]	宋金云, 王建芳, 赵宏宇. 慢性乙型肝炎和肝硬化患者血清HBV基因型分析[J]. 实用肝脏病杂志, 2021, 24(1): 87-90.
[15]	魏荣荣, 李爱玲, 李红, 张缭云. 慢性肝炎肝硬化和肝衰竭患者吲哚菁绿清除试验的变化及其临床意义[J]. 实用肝脏病杂志, 2021, 24(1): 91-94.